CompletedNot Applicable

Extended Platelet Rich Fibrin or Hyaluronate Enriched Xenografts for Horizontal Ridge Augmentation Via Subperiosteal Tunneling

Egypt34 participantsStarted 2024-03-01

Plain-language summary

Extended platelet rich fibrin or hyaluronate enriched xenografts will be used for horizontal maxillary ridge augmentation via subperiosteal tunneling to allow placement of dental implants six months later.

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * a maxillary anterior or premolar narrow ridge (width 3-6 mm), and adequate bone height (\>8 mm), seeking horizontal augmentation \& dental implant rehabilitation Exclusion Criteria: * systemic contraindications to surgery, local infection, untreated periodontal disease, heavy smoking, or pregnancy.

What they're measuring

horizontal bone gain measurement

Timeframe: 6months, 12 months

Trial details

NCT IDNCT07412535

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-01

View on ClinicalTrials.gov More Dental Implant trials